Selecta Biosciences, Inc.

SELB · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$36$16-$18-$35
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$10
Stock-Based Comp.$3$3$3-$2
Change in WC$9$7$0-$9
Other Non-Cash$9-$44-$9$40
Operating Cash Flow-$16-$18-$23$4
Investing Activities
PP&E Inv.-$1-$3-$1-$9
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0-$28
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$1-$3-$1-$37
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$40
Stock Repurch.$0$0$0-$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0-$8$196
Financing Cash Flow-$0$0-$8$196
Forex Effect-$0$0$0$0
Net Chg. in Cash-$17-$20-$32$133
Supplemental Information
Beg. Cash$162$182$214$81
End Cash$145$162$182$214
Free Cash Flow-$17-$20-$24-$5